Atlas Trials

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Clinical trial NCT03915860 · COMPLETED

Trial details

NCT number
NCT03915860
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2019-03-27
Primary completion
2019-12-23
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.